Revitalist Lifestyle and Wellness Ltd. Share Price Canadian Securities Exchange

Stocks

CALM

CA76151T1030

Healthcare Facilities & Services

OTC Markets Traded
Market Closed - 5-day change 1st Jan Change
- CAD -.--% Intraday chart for Revitalist Lifestyle and Wellness Ltd. -.--% -

Valuation : Revitalist Lifestyle and Wellness Ltd.

Market Cap 2.97M 2.56M 2.42M 2.19M 4.12M 284M 4.14M 28.76M 11.05M 144M 11.15M 10.9M 456M P/E 2021
-0.83x
P/E 2022 -0.12x
Enterprise Value 12.77M 11.01M 10.42M 9.44M 17.71M 1.22B 17.82M 124M 47.56M 620M 47.97M 46.91M 1.96B EV / Sales 2021
6,424,266x
EV / Sales 2022 369,034x
Free-Float
98.18%
Yield 2021 *
-
Yield 2022 -
5 years 0
Extreme 0
0.81
10 years 0
Extreme 0
0.88
Manager TitleAgeSince
Chief Operating Officer - 29/03/2023
Sales & Marketing - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 137
-0.66%-2.61%+27.97%+43.77% 122B
+1.36%+4.34%+8.26%+56.06% 91.19B
+0.75%+1.84%-4.70%+59.66% 29.28B
+1.68%-1.83%+30.47%+85.03% 25.51B
-0.13%+1.09%-2.23%-4.40% 21.69B
+0.09%+0.08%+37.50%+252.86% 21.21B
-1.18%+1.29%-4.52%+28.01% 16.28B
-0.13%-0.41%-9.30%-3.90% 11.86B
+0.12%-0.06%+37.27%+90.01% 11.56B
Average +0.19%+0.68%+13.41%+67.45% 38.94B
Weighted average by Cap. +0.25%+0.37%+16.54%+60.15%

Financials

2021 2022
Net sales 2.07 1.78 1.69 1.53 2.87 197.52 2.88 20.03 7.7 100.38 7.76 7.59 317.47 4.57 3.94 3.73 3.37 6.33 436.15 6.37 44.23 17 221.66 17.14 16.77 700.99
Net income -12.61M -10.87M -10.29M -9.32M -17.49M -1.2B -17.59M -122M -46.95M -612M -47.35M -46.31M -1.94B -13.63M -11.75M -11.12M -10.08M -18.9M -1.3B -19.01M -132M -50.75M -662M -51.18M -50.05M -2.09B
Net Debt 1.6 1.38 1.3 1.18 2.22 152.73 2.23 15.49 5.95 77.62 6 5.87 245.47 9.8 8.45 8 7.25 13.6 936.71 13.68 94.99 36.51 476.05 36.82 36.01 1.51K
Logo Revitalist Lifestyle and Wellness Ltd.
Revitalist Lifestyle and Wellness Ltd. is a mental health and wellness company focused on comprehensive care in the ketamine wellness space. The Company, through its Tennessee subsidiary, Revitalist LLC, operates physical locations in three states, virtual offices across six states and medical and behavioral services in two countries. The Company’s segments include Clinical Operations and Research. The Clinical Operations segment encompasses the Company’s ketamine assisted psychotherapy clinics across the United States. The Research segment consists of the development of virtual clinics in the metaverse and research focused expenses. The Company offers various therapies, such as Ketamine Therapy, Home Ketamine Therapy, Ketamine Assisted Psychotherapy, Spravato, Vitamin Therapy, Neuropeptide Therapy and Supplements. It offers treatment for various conditions, including Anxiety, Depression, PTSD, OCD, Bipolar Disorder, Pain, Suicidal Ideation and Substance Abuse.
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!